These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs. Rohdich N, Roepke RK, Zschiesche E. Parasit Vectors; 2014 Mar 04; 7():83. PubMed ID: 24593931 [Abstract] [Full Text] [Related]
4. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA. Karadzovska D, Chappell K, Coble S, Murphy M, Cavalleri D, Wiseman S, Drake J, Nanchen S. Parasit Vectors; 2017 Nov 01; 10(1):528. PubMed ID: 29089063 [Abstract] [Full Text] [Related]
5. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe. Becskei C, De Bock F, Illambas J, Mahabir SP, Farkas R, Six RH. Vet Parasitol; 2016 May 30; 222():49-55. PubMed ID: 26994516 [Abstract] [Full Text] [Related]
6. Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA. Kryda K, Mahabir SP, Inskeep T, Rugg J. Parasit Vectors; 2020 Mar 01; 13(1):98. PubMed ID: 32113472 [Abstract] [Full Text] [Related]
7. A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries. Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. Parasit Vectors; 2017 Nov 01; 10(1):526. PubMed ID: 29089065 [Abstract] [Full Text] [Related]
8. Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States. Cherni JA, Mahabir SP, Six RH. Vet Parasitol; 2016 May 30; 222():43-8. PubMed ID: 26947964 [Abstract] [Full Text] [Related]
9. A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling feline flea infestations. Meadows C, Guerino F, Sun F. Parasit Vectors; 2017 Jan 19; 10(1):37. PubMed ID: 28103942 [Abstract] [Full Text] [Related]
10. Clinical field study of the safety and efficacy of spinosad chewable tablets for controlling fleas on dogs. Robertson-Plouch C, Baker KA, Hozak RR, Zimmermann AG, Parks SC, Herr C, Hart LM, Jay J, Hutchens DE, Snyder DE. Vet Ther; 2008 Jan 19; 9(1):26-36. PubMed ID: 18415944 [Abstract] [Full Text] [Related]
11. Efficacy and safety of sarolaner (Simparica®) in the treatment and control of naturally occurring flea infestations in dogs presented as veterinary patients in Australia. Packianathan R, Colgan S, Hodge A, Davis K, Six RH, Maeder S. Parasit Vectors; 2017 Aug 16; 10(1):387. PubMed ID: 28814332 [Abstract] [Full Text] [Related]
12. Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs. Taenzler J, Wengenmayer C, Williams H, Fourie J, Zschiesche E, Roepke RK, Heckeroth AR. Parasit Vectors; 2014 Dec 04; 7():567. PubMed ID: 25471474 [Abstract] [Full Text] [Related]
13. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats. Rohdich N, Zschiesche E, Wolf O, Loehlein W, Pobel T, Gil MJ, Roepke RKA. Parasit Vectors; 2018 Nov 19; 11(1):598. PubMed ID: 30454052 [Abstract] [Full Text] [Related]
14. Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA. Dryden MW, Canfield MS, Kalosy K, Smith A, Crevoiserat L, McGrady JC, Foley KM, Green K, Tebaldi C, Smith V, Bennett T, Heaney K, Math L, Royal C, Sun F. Parasit Vectors; 2016 Jun 28; 9(1):365. PubMed ID: 27352607 [Abstract] [Full Text] [Related]
15. A small-scale open-label study of the treatment of canine flea allergy dermatitis with fluralaner. Fisara P, Shipstone M, von Berky A, von Berky J. Vet Dermatol; 2015 Dec 28; 26(6):417-20, e97-8. PubMed ID: 26271195 [Abstract] [Full Text] [Related]
16. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe. Cavalleri D, Murphy M, Seewald W, Nanchen S. Parasit Vectors; 2018 Jul 13; 11(1):410. PubMed ID: 30001744 [Abstract] [Full Text] [Related]
17. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA. Chappell K, Paarlberg T, Seewald W, Karadzovska D, Nanchen S. Parasit Vectors; 2021 Mar 01; 14(1):127. PubMed ID: 33648556 [Abstract] [Full Text] [Related]
18. Open field study on the efficacy of oral fluralaner for long-term control of flea allergy dermatitis in client-owned dogs in Ile-de-France region. Crosaz O, Chapelle E, Cochet-Faivre N, Ka D, Hubinois C, Guillot J. Parasit Vectors; 2016 Mar 23; 9():174. PubMed ID: 27007494 [Abstract] [Full Text] [Related]
19. Dog owner flea/tick medication purchases in the USA. Lavan R, Armstrong R, Tunceli K, Normile D. Parasit Vectors; 2018 Nov 06; 11(1):581. PubMed ID: 30400923 [Abstract] [Full Text] [Related]
20. A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment. Ranjan S, Young D, Sun F. Parasit Vectors; 2018 Jul 03; 11(1):385. PubMed ID: 29970135 [Abstract] [Full Text] [Related] Page: [Next] [New Search]